Moderna and Institut Pasteur Sign Strategic Research Collaboration

This article is over 11 years old

Published the 2 February 2015 Updated 14 October 2016

Moderna Therapeutics, a pioneer in the development of messenger RNA (mRNA) Therapeutics™ and the Institut Pasteur, today announced a long-term strategic research collaboration for the discovery and development of drugs and vaccines using Moderna’s mRNA Therapeutics™ platform. Valera, a Moderna venture company, will manage the research collaboration for Moderna.